EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genotype distribution of high-risk and potential high-risk HPV types among women in different screening and clinic settings in Ghana and Kenya

Eliza Mari Kwesi-Maliepaard iD, Judith A Osea-Larbi, Celestine K Nyamari, Yakubu Alhassan, Adelaide K Sromani, Vera M Kotey, Stephanie Darko, Randy Tackie, Ruth Kiome, Aisha M Mohammed, Erica Buadii, Emmanuel K Quaye und 18 weitere

PLOS One · 2026

DOI: 10.1371/journal.pone.0355868 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Eliza Mari Kwesi-Maliepaard und 29 weiteren Autor:innen. Beteiligte Einrichtung: Yemaachi Biotech Ltd, Accra, Ghana. Hauptthemen laut MEDLINE: Papillomavirus Infections, Uterine Cervical Neoplasms, Human Papillomavirus Viruses, Papillomaviridae. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yemaachi Biotech, Roche Products Ghana Limited and the Sanford Health Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The burden of cervical cancer is highest in Africa. Human papillomavirus (HPV) infection is the major cause of cervical cancer. There are over 200 different HPV genotypes, with 15 considered (potential) high-risk genotypes for developing cancer. Due to a lack of systematic screening programs in most African countries, there is limited data available on the most prevalent HPV genotypes in the population. This study aimed to assess the prevalence and distribution of HPV genotypes in cohorts in Ghana and Kenya.

Methods

We analyzed HPV genotyping data from cervical samples submitted for diagnostic HPV genotype testing between July 2022 and March 2025. Our database contained results from samples obtained from outreach screening events in Accra, the capital of Ghana (n = 680), a research project in Ghana outside of Accra (n = 426), clinician-collected samples submitted through clinics in Ghana (n = 118), samples from participants in Ghana who independently sought HPV genotyping through community-based providers, pharmacies, clinics, or online testing services outside organized screening programmes (n = 181) and samples from an outreach screening event in Kenya (n = 46). All samples were from women 18 years old and above. Positivity for HPV genotypes (HPV-16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68) was determined by RT-PCR, using the AmpFire HPV High Risk Genotyping kit.

Results

HPV positivity in the Ghana screening group was 34.9%, with multiple genotypes detected in 39.2% of the positive cases. The main HPV genotype in the Ghana screening group was HPV-39 (19.0%), which was especially prevalent in the younger age group (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsUterine Cervical NeoplasmsHuman Papillomavirus VirusesPapillomaviridaeHumansFemaleKenyaGhanaGenotypeAdultMiddle AgedYoung AdultMass ScreeningPrevalenceAdolescentEarly Detection of Cancer

Autor:innen und Institutionen

  • Yemaachi Biotech Ltd, Accra, Ghana.
  • West African Genetic Medicine Centre, University of Ghana, Accra, Ghana.
  • Department of Biostatistics, School of Public Health, University of Ghana, Accra, Ghana.
  • West African Centre for Cell Biology of Infectious Pathogens, University of Ghana, Accra, Ghana.
  • Biochemistry, Cell and Molecular Biology Dept, University of Ghana, Accra, Ghana.
  • Sanford World Clinic, Mankessim, Ghana.

ORCID-Profile: Eliza Mari Kwesi-Maliepaard, Barikisu A Ibrahim, Charles Ochieng' Olwal, David Hutchful, Emmanuella Amoako, Frank G Onyambu

Förderung

  • Yemaachi Biotech
  • Roche Products Ghana Limited and the Sanford Health Foundation

Zitieren

APA

Kwesi-Maliepaard, E. M., Osea-Larbi, J. A., Nyamari, C. K., Alhassan, Y., Sromani, A. K., Kotey, V. M., Darko, S., Tackie, R., Kiome, R., Mohammed, A. M., Buadii, E., Quaye, E. K., Akligoh, H., Ibrahim, B. A., Kaba, P., Amoako, S. F., Kotey, E., Agyemang, S., Ngoi, J. M., …, & Bediako, Y. (2026). Genotype distribution of high-risk and potential high-risk HPV types among women in different screening and clinic settings in Ghana and Kenya. PLOS One. https://doi.org/10.1371/journal.pone.0355868

Vancouver

Kwesi-Maliepaard EM, Osea-Larbi JA, Nyamari CK, Alhassan Y, Sromani AK, Kotey VM, et al. Genotype distribution of high-risk and potential high-risk HPV types among women in different screening and clinic settings in Ghana and Kenya. PLOS One. 2026. doi:10.1371/journal.pone.0355868

BibTeX
@article{KwesiMaliepaard2026,
  author = {Kwesi-Maliepaard, Eliza Mari and Osea-Larbi, Judith A and Nyamari, Celestine K and Alhassan, Yakubu and Sromani, Adelaide K and Kotey, Vera M and Darko, Stephanie and Tackie, Randy and Kiome, Ruth and Mohammed, Aisha M and Buadii, Erica and Quaye, Emmanuel K and Akligoh, Harry and Ibrahim, Barikisu A and Kaba, Patricia and Amoako, Susan Florence and Kotey, Esmy and Agyemang, Seth and Ngoi, Joyce M and Paemka, Lily and Darkwa, Kwaku and Degley, Thywill and Siebu, Nathan Edward and Olwal, Charles Ochieng' and Morang'a, Collins M and Manu, Aida and Hutchful, David and Amoako, Emmanuella and Onyambu, Frank G and Bediako, Yaw},
  title = {Genotype distribution of high-risk and potential high-risk HPV types among women in different screening and clinic settings in Ghana and Kenya},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0355868}
}
Kostenlos starten →